BIBioceres Crop Solutions Corp. BIOX · NASDAQ
$0.22 +6.59% (+$0.01)
- Market cap
- $14.0M
- Enterprise value
- $239.6M
- P/E
- -
- Forward P/E
- 4.4x
- PEG
- -
- P/S
- 0.1x
- P/FCF
- 0.3x
- EV/EBITDA
- 90.2x
- ROIC
- -0.3%
- Gross margin
- 35.4%
- Net margin
- -93.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 84.9x
- Beta
- 0.47
- Free float
- 71.2%
About the company
Bioceres Crop Solutions Corp. (BIOX) is a company specializing in the development and delivery of innovative agrotechnological solutions for agriculture. Headquartered in Argentina, the company operates internationally. The company focuses on providing technologies that enhance crop productivity, sustainability, and resilience in various agricultural conditions. Bioceres Crop Solutions also engages in the development of biotechnological products, including genetically modified crops that can improve resistance to pests and adverse conditions. Shares of Bioceres Crop Solutions Corp. (BIOX) can be an appealing choice for investors seeking investment opportunities in the field of agrotechnologies and sustainable agriculture.
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Federico Trucco
Employees
751
Headquarters
Rosario
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue growth is slowing: 0.5% a year over the last 3 years against 14% over 5 years.
- What to watch: It missed profit estimates 7 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 22 USD is left as free cash.
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: Repaying its net debt would take 84.9 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It bought back its own shares for $926.9K in the last fiscal year, 6.6% of its market value.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number